Recognition of the respective native epitopes was tested by recognition of autologous EBV-B cells engineered to express MAGE-A3 either in the cytoplasm or in the endosomal/lysosomal compartment and the HLA-class II positive autologous melanoma. Here, MAGEA3 is linked to melanoma.